I read this morning that NHS England have secured a deal with the manufacturer of the immunotherapy drug Pembrolizumab (marketed under the brand name Keytruda) for early stage TNBC. Currently it is used further down the path for people with unresectable secondaries where chemo hasn’t removed the cancer. It is a targeted therapy for tumours expressing PD-L1, so not all cases of TNBC will benefit.
Hi coddfish
Im not from this group. I usually hang out in head and neck cancer but I just wanted to add a comment. This is welcome news. Pembro is used in recurrent HNC and I have often wondered if it would be an effective first line drug. Having more available must surely be a good thing.
Dani
Base of tongue cancer. T2N0M0 6 weeks Radiotherapy finished January 2019
I wrote a blog about my cancer. just click on the link below
I have been having this coinciding with chemo, I have it every 3 weeks. I’m the third person at the hospital to be offered it.
Yes it’s been fine, but I only have once every 3 weeks so I have only had one dose. Got my second tomorrow
Hi All,
I am also on pembrolizumab. My neighbours were actually part of the team that designed the drug and they have said that it will revolutionise cancer care. It already has great feedback in the treatment of brain and lung cancer so hopefully we will see good results.
I have had my first dose two weeks ago which went well and due my second next week.
Best wishes
Jemma
Must be quite interesting benefiting from a drug that your neighbours had a role in creating. I expect they will be very interested in your direct experience
Yes I imagine they will. Its just very reassuring to know that medicine is always making advancements and that we are eligible for these new drugs. I feel lucky in that respect.
Hi Melsbels
I hope yours is going well too! It's nice to virtually meet others also on a similar treatment x
Whatever cancer throws your way, we’re right there with you.
We’re here to provide physical, financial and emotional support.
© Macmillan Cancer Support 2024 © Macmillan Cancer Support, registered charity in England and Wales (261017), Scotland (SC039907) and the Isle of Man (604). Also operating in Northern Ireland. A company limited by guarantee, registered in England and Wales company number 2400969. Isle of Man company number 4694F. Registered office: 3rd Floor, Bronze Building, The Forge, 105 Sumner Street, London, SE1 9HZ. VAT no: 668265007